Dr. Roloff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
# MC2115
Chicago, IL 60637Phone+1 773-702-2731
Education & Training
Loyola University Medical CenterResidency, Internal Medicine, 2018 - 2021
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2018
National Institutes of Health / National Heart, Lung, and Blood InstituteMedical Research Scholar, Myeloid Malignancies , 2016 - 2017
Certifications & Licensure
IL State Medical License 2018 - 2026
IN State Medical License 2024 - 2025
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Alpha Omega Alpha Stritch School of Medicine, 2020
- Henry E. and Loretta A. Jordan Award for Noteworthy Investigation in Cancer and Neoplastic Diseases University at Buffalo School of Medicine, 2018
- Research Honors University at Buffalo School of Medicine, 2018
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsOutcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL.Gregory W Roloff, Ibrahim Aldoss, Noam E Kopmar, Chenyu Lin, Simone E Dekker
Journal of Clinical Oncology. 2025-02-10 - 2 citationsImpact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL.Ibrahim Aldoss, Gregory W Roloff, Rawan Faramand, Noam E Kopmar, Chenyu Lin
Blood Advances. 2024-12-10 - Somatic co-alteration signatures are prognostic in high-grade TP53-mutated myeloid neoplasms.Emily O Symes, Peng Wang, Payal Sojitra, Madhu P Menon, Anand A Patel
British Journal of Haematology. 2024-11-17
Journal Articles
- Inherited Susceptibility to Hematopoietic Malignancies in the Era of Precision OncologyGregory W Roloff, Michael W Drazer, Lucy A Godley, JCO Precision Oncology, 1/11/2021
- Next-Generation Sequencing Delineates Clonal Origins and Informs Therapeutic Strategies in Acute Lymphoblastic Leukemia and Histiocytic SarcomaGregory W Roloff, Jeffrey I Baron, Vishala T Neppalli, Sheila Sait, Elizabeth A Griffiths, JCO Precision Oncology, 9/9/2019
Professional Memberships
- American Society of HematologyMember
- Phi Beta KappaMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
